Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20993533 | 0.97 | TSHR (0.60) | ALDH1A1LMNATSHRNFKB1PMP22 | |
| SCHEMBL21703159 | 0.97 | TSHR (0.60) | ALDH1A1LMNATSHRNFKB1PMP22 | |
| SCHEMBL4815884 | 0.97 | TSHR (0.60) | ALDH1A1LMNATSHRNFKB1PMP22 | |
| SCHEMBL6688889 | 0.95 | ALDH1A1 (0.61) | ALDH1A1LMNATSHRNFKB1PMP22 | |
| SCHEMBL131476 | 0.89 | ALDH1A1 (0.74) | ALDH1A1LMNACHRNB2CHRNB4CHRNA4 | |
| SCHEMBL3189950 | 0.86 | ALDH1A1 (0.70) | ALDH1A1LMNATSHRNFKB1PMP22 | |
| SCHEMBL15217119 | 0.85 | EPHX2 (0.64) | ALDH1A1LMNAPPARGPPARDPPARA | |
| SCHEMBL12886622 | 0.84 | EPHX2 (0.62) | ALDH1A1LMNAPPARGPPARDPPARA | |
| SCHEMBL322794 | 0.83 | PHF8 (0.64) | ALDH1A1LMNASLC22A6OR51E2CHRNB2 | |
| SCHEMBL5948495 | 0.83 | ALDH1A1 (0.74) | ALDH1A1LMNATSHRSLC22A6HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8197588-B2 | Use of amides and/or polyamides as auxiliary agents for asphalt and bitumen compositions | Cognia IP Management GmbH (DE) | 2012-06-12 | — | — | US | disclosed |
| EP-2345702-A1 | Paint and coating remover compositions | Cognis IP Management GmbH (DE) | 2011-07-20 | — | — | EP | disclosed |
| US-20110118391-A1 | USE OF AMIDES AND/OR POLYAMIDES AS AUXILIARY AGENTS FOR ASPHALT AND BITUMEN COMPOSITIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2011-05-19 | — | — | US | disclosed |
| WO-2009103445-A1 | USE OF AMIDES AND/OR POLYAMIDES AS AUXILIARY AGENTS FOR ASPHALT AND BITUMEN COMPOSITIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2009-08-27 | — | — | WO | disclosed |
| EP-2093257-A1 | Use of amides and/or polyamides as auxiliary agents for asphalt and bitumen compositions | Cognis IP Management GmbH (DE) | 2009-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118391-A1 | USE OF AMIDES AND/OR POLYAMIDES AS AUXILIARY AGENTS FOR ASPHALT AND BITUMEN COMPOSITIONS | SRM, NAAA, CEPT1 | ALDH1A1 3523/4885LMNA 484/4885TSHR 4746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.